-
Signature
-
/s/ Jillian Forusz, as attorney-in-fact
-
Stock symbol
-
ADBE
-
Transactions as of
-
Apr 15, 2024
-
Transactions value $
-
-$114,695
-
Form type
-
4
-
Date filed
-
4/17/2024, 04:49 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+190 |
+4.66% |
$0.00 |
4.26K |
Apr 15, 2024 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$44.2K |
-94 |
-2.2% |
$470.10 |
4.17K |
Apr 15, 2024 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+109 |
+2.61% |
$0.00 |
4.28K |
Apr 15, 2024 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$25.4K |
-54 |
-1.26% |
$470.10 |
4.22K |
Apr 15, 2024 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Sale |
-$45.1K |
-96 |
-2.27% |
$470.00 |
4.13K |
Apr 16, 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-190 |
-8.33% |
$0.00 |
2.09K |
Apr 15, 2024 |
Common Stock |
190 |
$0.00 |
Direct |
F3 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-109 |
-6.23% |
$0.00 |
1.64K |
Apr 15, 2024 |
Common Stock |
109 |
$0.00 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: